RCT of Misoprostol for Postpartum Hemorrhage in India
Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
Death rates for pregnant women in rural India are approximately forty-five times higher than
in the United States. Bleeding after the birth of a child and underlying anemia are the
primary causes of mothers' deaths and sickness in rural India. This study assesses the
effectiveness of an oral drug, misoprostol, given in the late stage of labor to reduce the
incidence of maternal bleeding following births assisted by midwives in selected sites in
Belgaum District, Karnataka, India.
Phase:
N/A
Details
Lead Sponsor:
NICHD Global Network for Women's and Children's Health
Collaborators:
Bill and Melinda Gates Foundation Fogarty International Center of the National Institute of Health Global Network for Women's and Children's Health Research Jawaharlal Nehru Medical College John E. Fogarty International Center (FIC) National Cancer Institute (NCI) National Center for Complementary and Integrative Health (NCCIH) National Institute of Dental and Craniofacial Research (NIDCR) RTI International University of Missouri-Columbia